HSCS — HeartSciences Share News
0.000.00%
Last trade - 00:00- $15.26m
- $18.96m
- $0.00m
Brief: Fortitude Provides Second Quarter 2026 Financial And Operating Highlights
Brief: Fortitude Invests $1.0 Million In Heartsciences At A 22% Premium With No Adjustment To The Merger Consideration
Brief: Heartsciences - Files Preliminary Proxy For Business Combination With Fortitude Mining Holdings
Brief: Heartsciences Signs First Saas Revenues Agreement Following Full Launch Of Myovista Insights™
Brief: HeartSciences Files FDA 510(k) for MyoVista WaveCG Device
Brief: HeartSciences Enters Amendment No. 7 To Loan Agreement - SEC Filing
Brief: HeartSciences Signs First MyoVista Insights™ Platform Customer
Brief: Heartsciences Provides Business Update And Reports Second Quarter Fiscal 2025 Financial Results
Brief: Heartsciences Regains Compliance With Nasdaq Listing Requirements
Brief: Heart Test Laboratories Receives Staff Determination From Nasdaq To Delist Co's Securities From Nasdaq Capital Market
Brief: HeartSciences Announces Canada Patent Grant Covering MyoVista Wavelet Technology
Brief: Heart Test Laboratories Says There Was No Significant Revenue In The Second Fiscal Quarter 2024
Brief: Matthews Holdings Southwest Reports 8.1% Passive Stake In Heart Test Laboratories As Of Nov 15 - SEC Filing
Brief: Heartsciences Receives FDA Confirmation For 510(K) Clearance Pathway
Brief: Heartsciences Receives FDA Confirmation For 510(K) Clearance Pathway
Brief: Icahn School Of Medicine At Mount Sinai Reports 9.9% Passive Stake In Heart Test Laboratories
Brief: HeartSciences Closes License Agreements with the Icahn School of Medicine to Develop and Commercialize AI Cardiovascular Algorithms
U.S. STOCKS ON THE MOVE-Sirius XM, Spirit Airlines, Canoo
Brief: Heart Test Laboratories Says Entered Into Agreements With Icahn Mount Sinai